Protective effect of leptin and ghrelin against toxicity induced by amyloid-β oligomers in a hypothalamic cell Line

Journal of Neuroendocrinology

Volumn 26, Issue 3, 2014, Pages 176-185

  Gomes, S ^a   Martins, I ^a   Fonseca, A C R G ^b   Oliveira, C R ^b,c   Resende, R ^b   Pereira, C M F ^b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Alzheimer's disease; Amyloid oligomers; Ghrelin; Hypothalamus; Leptin; Mitochondrial dysfunction

Indexed keywords

AMYLODI BETA OLIGOMER; AMYLOID BETA PROTEIN; CALCIUM; CASPASE 3; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; GHRELIN; GHRELIN RECEPTOR; LEPTIN; NEUROPROTECTIVE AGENT; OLIGOMER; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG; AMYLOID BETA-PROTEIN (1-42); BIOPOLYMER; PEPTIDE FRAGMENT;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EMBRYO; HOMEOSTASIS; HYPOTHALAMUS; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; DRUG EFFECTS; METABOLISM; TOXICITY;

AMYLOID BETA-PEPTIDES; ANIMALS; BIOPOLYMERS; CALCIUM; CELL LINE; GHRELIN; HYPOTHALAMUS; LEPTIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; PEPTIDE FRAGMENTS; REACTIVE OXYGEN SPECIES;

EID: 84897877226     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/jne.12138     Document Type: Article

References (47)

1. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21-34.
2. Diano S, Farr SA, Benoit SC, McNay EC, da Silva I, Horvath B, Gaskin FS, Nonaka N, Jaeger LB, Banks WA, Morley JE, Pinto S, Sherwin RS, Xu L, Yamada KA, Sleeman MW, Tschöp MH, Horvath TL. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 2006; 9: 381-388.
3. Oomura Y, Hori N, Shiraishi T, Fukunaga K, Takeda H, Tsuji M, Matsumiya T, Ishibashi M, Aou S, Li XL, Kohno D, Uramura K, Sougawa H, Yada T, Wayner MJ, Sasaki K. Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats. Peptides 2006; 27: 2738-2749.
4. van de Nes JA, Kamphorst W, Ravid R, Swaab DF. Comparison of beta-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol 1998; 96: 129-138.
5. Smith KL, Greenwood CE. Weight loss and nutritional considerations in Alzheimer disease. J Nutr Elder 2008; 27: 381-403.
6. Wang PN, Yang CL, Lin KN, Chen WT, Chwang LC, Liu HC. Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study. J Neurol 2004; 251: 314-320.
7. Tamura BK, Masaki KH, Blanchette P. Weight loss in patients with Alzheimer's disease. J Nutr Elder 2007; 26: 21-38.
8. Gahete MD, Rubio A, Córdoba-Chacón J, Gracia-Navarro F, Kineman RD, Avila J, Luque RM, Castaño JP. Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. J Alzheimers Dis 2010; 22: 819-828.
9. Harvey J. Leptin: the missing link in Alzheimer disease? Clin Chem 2010; 56: 696-697.
10. Akimoto Y, Kanai S, Ohta M, Akimoto S, Uematsu H, Miyasaka K. Age-associated reduction of stimulatory effect of ghrelin on food intake in mice. Arch Gerontol Geriatr 2012; 55: 238-243.
11. Fewlass DC, Noboa K, Pi-Sunyer FX, Jonhston JM, Yan SD, Tezapsidis N. Obesity-related leptin regulates Alzheimer's Aβ. FASEB J 2004; 18: 1870-1878.
12. Greco SJ, Sarkar S, Johnston JM, Zhu X, Su B, Smith MA, Tezapsidis N. Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. Biochem Biophys Res Commun 2008; 376: 536-541.
13. Greco SJ, Bryan KJ, Sarkar S, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N, Casadesus G. Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J Alzheimers Dis 2010; 19: 1155-1167.
14. Moon M, Choi JG, Nam DW, Hong HS, Choi YJ, Oh MS, Mook-Jung I. Ghrelin ameliorates cognitive dysfunction and neurodegeneration in intrahippocampal amyloid-β1-42 oligomer-injected mice. J Alzheimers Dis 2011; 23: 147-159.
15. Ferrini F, Salio C, Lossi L, Merighi A. Ghrelin in central neurons. Curr Neuropharmacol 2009; 7: 37-49.
16. Tang BL. Leptin as a neuroprotective agent. Biochem Biophys Res Commun 2008; 368: 181-185.
17. Bajda M, Guzior N, Ignasik M, Malawska B. Multi-target-directed ligands in Alzheimer's disease treatment. Curr Med Chem 2011; 18: 4949-4975.
18. Resende R, Moreira PI, Proença T, Deshpande A, Busciglio J, Pereira C, Oliveira CR. Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radic Biol Med 2008b; 44: 2051-2057.
19. Resende R, Ferreiro E, Pereira C. Resende de Oliveira C. Neurotoxic effect of oligomeric and fibrillar species of amyloid-beta peptide 1-42: involvement of endoplasmic reticulum calcium release in oligomer-induced cell death. Neuroscience 2008a; 155: 725-737.
20. Ferreira IL, Bajouco LM, Mota SI, Auberson YP, Oliveira CR, Rego AC. Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. Cell Calcium 2012; 51: 95-106.
21. 2+ uptake. Neurochem Res 1990; 15: 313-320.
22. Cregan SP, MacLaurin JG, Craig CG, Robertson GS, Nicholson DW, Park DS, Slack RS. Bax-dependent caspase-3 activation is a key determinant in p-53-induced apoptosis in neurons. J Neurosci 1999; 19: 7860-7869.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival. J Immunol Methods 1983; 65: 55-63.
24. Chung H, Kim E, Lee DH, Seo S, Ju S, Lee D, Kim H, Park S. Ghrelin inhibits apoptosis in hypothalamic neuronal cells during oxygen-glucose deprivation. Endocrinology 2007; 148: 148-159.
25. Martins I, Gomes S, Costa RO, Otvos L, Oliveira CR, Resende R, Pereira CM. Leptin and ghrelin prevent hippocampal dysfunction induced by Aβ oligomers. Neuroscience 2013; 241: 41-51.
26. Deshpande A, Mina E, Glabe C, Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 2006; 26: 6011-6018.
27. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH. A specific amyloid-β protein assembly in the brain impairs memory. Nature 2006; 440: 352-357.
28. Ferreiro E, Eufrásio A, Pereira C, Oliveira CR, Rego AC. Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. J Alzheimers Dis 2007; 12: 223-228.
29. Schmitt K, Grimm A, Kazmierczak A, Strosznajder JB, Götz J, Eckert A. Insights into mitochondrial dysfunction: aging, amyloid-β, and tau-A deleterious trio. Antioxid Redox Signal 2012; 16: 1456-1466.
30. Cha MY, Han SH, Son SM, Hong HS, Choi YJ, Byun J, Mook-Jung I. Mitochondria-specific accumulation of amyloid β induces mitochondrial dysfunction leading to apoptotic cell death. PLoS ONE 2012; 7: e34929.
31. Ferreiro E, Oliveira CR, Pereira CM. The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway. Neurobiol Dis 2008; 30: 331-342.
32. Andrews ZB, Erion D, Beiler R, Liu ZW, Abizaid A, Zigman J, Elsworth JD, Savitt JM, DiMarchi R, Tschoep M, Roth RH, Gao XB, Horvath TL. Ghrelin promotes and protects nigrostriatal dopamine function via a UCP2-dependent mitochondrial mechanism. J Neurosci 2009; 29: 14057-14065.
33. Guo Z, Jiang H, Xu X, Duan W, Mattson MP. Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J Biol Chem 2008; 283: 1754-1763.
34. Ho PW, Liu H, Ho JW, Zhang W, Chu AC, Kwok KH, Ge X, Chan K, Ramdsen DB, Ho S. Mitochondrial uncoupling protein-2 (UCP2) mediates leptin protection against MPP+ toxicity in neuronal cells. Neurotox Res 2010; 17: 332-343.
35. Jiang H, Li LJ, Wang J, Xie JX. Ghrelin antagonizes MPTP-induced neurotoxicity to the dopaminergic neurons in mouse substantia nigra. Exp Neurol 2008; 212: 532-537.
36. Chung H, Chung HY, Bae CW, Kim CJ, Park S. Ghrelin suppresses tunicamycin- or thapsigargin-triggered endoplasmic reticulum stress-mediated apoptosis in primary cultured rat cortical neuronal cells. Endocr J 2011; 58: 409-420.
37. Valerio A, Ghisi V, Dossena M, Tonello C, Giordano A, Frontini A, Ferrario M, Pizzi M, Spano P, Carruba MO, Nisoli E. Leptin increases axonal growth cone size in developing mouse cortical neurons by convergent signals inactivating glycogen synthase kinase-3beta. J Biol Chem 2006; 281: 12950-12958.
38. Greco SJ, Sarkar S, Casadesus G, Zhu X, Smith MA, Ashford JW, Johnston JM, Tezapsidis N. Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. Neurosci Lett 2009; 455: 191-194.
39. Doherty GH, Beccano-Kelly D, Yan SD, Gunn-Moore FJ, Harvey J. Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid β. Neurobiol Aging 2013; 34: 226-237.
40. Chen Y, Cao CP, Li CR, Wang W, Zhang D, Han LL, Zhang XQ, Kim A, Kim S, Liu GL. Ghrelin modulates insulin sensitivity and tau phosphorylation in high glucose-induced hippocampal neurons. Biol Pharm Bull 2010; 33: 1165-1169.
41. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 97: 353-356.
42. Power DA, Noel J, Collins R, O'Neill D. Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement Geriatr Cogn Disord 2001; 12: 167-170.
43. Holden KF, Lindquist K, Tylavsky FA, Rosano C, Harris TB, Yaffe K. Serum leptin level and cognition in the elderly: findings from the Health ABC Study. Neurobiol Aging 2009; 30: 1483-1489.
44. Lieb W, Beiser AS, Vasan RS, Tan ZS, Au R, Harris TB, Roubenoff R, Auerbach S, DeCarli C, Wolf PA, Seshadri S. Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 2009; 302: 2565-2572.
45. Bonda DJ, Stone JG, Torres SL, Siedlak SL, Perry G, Kryscio R, Jicha G, Casadesus G, Smith MA, Zhu X, Lee HG. Dysregulation of leptin signaling in Alzheimer disease: evidence for neuronal leptin resistance. J Neurochem 2014;128: 162-172.
46. Banks WA. Role of the blood-brain barrier in the evolution of feeding and cognition. Ann NY Acad Sci 2012; 1264: 13-19.
47. Kmieć Z, Pétervári E, Balaskó M, Székely M. Anorexia of aging. Vitam Horm 2013; 92: 319-355.